ClinicalTrials.govpublic full text
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
breast cancer, ovarian function suppression (ofs), aromatase inhibitors(ais), tamoxifen(tam), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908347
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.